PTX 7.32% 4.4¢ prescient therapeutics limited

Ann: Canadian Patent Granted for PTX-200, page-13

  1. 87 Posts.
    lightbulb Created with Sketch. 13

    PTX is fully-funded to fast-track development on key projects. Recently completed capital raising amounted to $9.1 Million.
    US based H.C. WAINWRIGHT & CO. EQUITY RESEARCH initiateda coverage recently with a Buy rating and $A0.20 price target.
    Expecting numerous catalyst/news flow in the near term.


    https://hotcopper.com.au/data/attachments/1554/1554658-aaa28689a90d8856533f82c18119f95a.jpg

    Credit Suisse took position at a buy price of 0.05 cents on1-9 April 2019.

    https://hotcopper.com.au/data/attachments/1554/1554662-69bd8f51690d06ac74d7ba32254e39f9.jpg


    Regal Funds & Australian Ethical Investments are majorshareholders.

    https://hotcopper.com.au/data/attachments/1554/1554659-eecf4897f44c886f62b67413bdc069a9.jpg


 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.003(7.32%)
Mkt cap ! $35.43M
Open High Low Value Volume
4.1¢ 4.4¢ 4.0¢ $20.95K 507.0K

Buyers (Bids)

No. Vol. Price($)
8 216927 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 238807 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.